US Stock MarketDetailed Quotes

BZ Kanzhun

Watchlist

16.625 +0.125+0.76% Trading 11/29 12:31 ET

16.810High16.150Low1.47MVolume

Kanzhun Stock Forum

Moomoo AI

11/16 21:46

Kanzhun's effective reinvestment activities steering it to profitability is commendable, suggesting a good investment opportunity despite the modest 4.8% return delivered to shareholders over the past year.

Returns Are Gaining Momentum At Kanzhun (NASDAQ:BZ)

Mooers Radar

08/04 08:29

ColumnsUS Top Gap Ups and Downs on 8/3: REGN, PYPL, QCOM, MCK and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Clorox(CLX.US)$ - up 4.6%
2. $Cognizant(CTSH.US)$ - up 4.1%
3. $Informatica(INFA.US)$ - up 2.8%
4. $Kanzhun(BZ.US)$ - up 2.7%
5. $Sunrun(RUN.US)$ - up 2.6%
6. $Regeneron Pharmaceuticals(REGN.US)$ - up 1.9%
7. $McKesson(MCK.US)$ - up 1.9%
8. $Curtiss-Wright(CW.US)$ - up 1.7%
9. $MercadoLibre(MELI.US)$ - up 1.5...

+16

Mooers Radar

07/13 08:16

ColumnsUS Top Gap Ups and Downs on 7/12: DPZ, JEF, NWG, ACHC and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Domino's Pizza(DPZ.US)$ - up 8.7%
2. $POSCO(PKX.US)$ - up 5.2%
3. $Fresenius Medical Care(FMS.US)$ - up 4.6%
4. $Jefferies Financial(JEF.US)$ - up 3.8%
5. $STMicroelectronics(STM.US)$ - up 3.8%
6. $Kanzhun(BZ.US)$ - up 3.8%
7. $Bilibili(BILI.US)$ - up 3.7%
8. $Rio Tinto(RIO.US)$ - up 3....

+11

FiReBiTriXiE

05/23 22:38

I’m in here Because a Zacks Rating of Strong Buy

$Kanzhun(BZ.US)$ so you’re looking good to Zacks model for him to place you in his top 5%(strong buy)of 4000 stocks aye? Not even just a Buy rating which is his next 15% of 4000 stocks! You definitely have to be something special to get a STRONG BUY RATING by Zack dudes model is a genius!Lets give her a go! Now im debating if i ahould have waited till after earnings report.🤔😅 Well if you cant take risks whats the point!!’ All in!!! ♥️🔥🦅♾

Mooers Radar

04/06 17:05

ColumnsUS Top Gap Ups and Downs on 4/5: AU, AZN, AEP, ALB and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $AngloGold Ashanti(AU.US)$ - up 2.2%
2. $AstraZeneca(AZN.US)$ - up 1.7%
3. $argenx SE(ARGX.US)$ - up 1.4%
4. $American Electric Power(AEP.US)$ - up 0.4%
5. $AmerisourceBergen(ABC.US)$ - up 0.3%
Gap Downs
1. $Albemarle(ALB.US)$ - down 2.9%
2. $ABB Ltd(ABB.US)$ - down 0.9%
3. $Kanzhun(BZ.US)$ - down 0....

+10

Value Never Lie

03/22 15:07

ColumnsBOSS Zhipin (BZ) Financial Report Review: User growth is stable, and the urban service industry is expected to contribute new growth

BOSS Zhipin released its financial report for 2022. In 22Q4, it achieved revenue of 1.082 billion yuan (RMB, unless otherwise specified, the same below), which was flat year-on-year and fell by 8.2% month-on-month, mainly due to the impact of the epidemic. Among them, the online recruitment service business achieved revenue of 1.070 billion yuan, a year-on-year decr...

Stocks & Markets Analysis

Senorita Earnings

03/22 10:53

ColumnsExpert Meeting Minutes | Kanzhun Limited 22Q4 and Annual Performance Exchange

Core points:
1. In the fourth quarter, the company realized non-GAAP cash receipts (Non-GAAP) of RMB 1.1 billion, and GAAP income of RMB 1.08 billion, which was the same as the same period last year. For the full year of 2022, the company will achieve GAAP revenue of RMB 4.51 billion, and the calculated cash receipts (Non-GAAP) will be RMB 4.61 billion.
2. In the fourth quarter, the company did two major things. On Dece...

Noah Johnson

03/21 16:42

ColumnsKANZHUN 22Q4 Earning Report: Performance Growth is Confirmed, But the Valuation Premium is too High

1. 22Q4 revenue is affected by macro headwinds, and the optimistic 23Q1 performance guidance is mainly driven by economic recovery
KANZHUN's 22Q4 revenue was 1.0823 billion yuan, a slight decline of less than 1% year-on-year. The revenue in 2022 will be 4.511 billion yuan, YoY+5.9%, slightly exceeding market expectations, reflecting that the company still maintains a certain degree of competitivene...

Stocks & Markets Analysis

GAME_DAY

03/20 05:11

TOP WATCH 3/20 ⚡️⚡️

$Boxed(BOXD.US)$$Kanzhun(BZ.US)$$Corbus Pharmaceuticals(CRBP.US)$$Darling Ingredients(DAR.US)$$Diebold Nixdorf(DBD.US)$$Dell Technologies(DELL.US)$$Equinox Gold(EQX.US)$$Getaround(GETR.US)$$Gelesis Holdings(GLS.US)$$Kinross Gold(KGC.US)$$LanzaTech Global(LNZA.US)$$MicroStrategy(MSTR.US)$$PaxMedica(PXMD.US)$$Science 37(SNCE.US)$$Toyota Motor(TM.US)$

To the Moo

03/06 15:03

Form 13F filing period arrives! Wall Street Capital profits from Chinese stocks

Recently, major institutions filed 13F reports with the U.S. Securities and Exchange Commission (SEC), disclosing their holdings and the size of their positions in U.S. stocks during the fourth quarter.
It is worth noting that large Wall Street private equity funds are buying Chinese stocks on a large scale, and the allocation strategy for Chinese stocks has gradually shifted from [underweight] to [Neutral]!